Back to
VANGUARD GROUP INC
LENZ6 quarters
Position history for
VANGUARD GROUP INC's holdings in LENZ THERAPEUTICS INC
As of its last 13F, for Q4 2025, Vanguard Group held 1,321,202 shares of LENZ (Lenz Therapeutics), worth $21.1M. It reduced the position by 9,084 shares (-0.7%) from Q3 2025. Vanguard Group held LENZ from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.
Current Value
$21.1M
Current Shares
1.3M
Total Value Change
-$5.4M
Total Shares Change
+202,385
Quarter-by-Quarter History
Other major holders of LENZ: RA CAPITAL MANAGEMENT, L.P.